Rennie - instructions for use, dose, side effects, contraindications

Active substanceCalcium carbonate + Magnesium carbonateCalcium carbonate + Magnesium carbonate

Similar drugsTo uncover

Ramni®

pills inwards

TATHIMFARMPREPARATY, JSC Russia

Rennie®

pills locally inwards

BAYER, AO Russia

Rennie®

pills locally inwards

BAYER, AO Russia

Dosage form: & nbspchewing tablets, chewing tablets [cooling taste]

Composition:

1 chewable tablet contains:

Active substances:

calcium carbonate 680 mg

magnesium carbonate basic 80 mg

Excipients:

sucrose 475 mg, corn pregelatinized corn starch 20 mg, potato starch 13 mg, talc 33.14 mg, magnesium stearate 10.66 mg, light liquid paraffin 5 mg, flavoring menthol (peppermint oil, maltodextrin, gum arabic, silicon dioxide) 13 mg , lemon flavor (lemon oil, maltodextrin, water) 0.2 mg.

1 tablet chewing [cooling taste] contains:

Active substances:

calcium carbonate 680 mg

magnesium carbonate basic 80 mg

Auxiliary substances: sucrose 475 mg, corn pregelatinized corn starch 20 mg, potato starch 13 mg, talc 33.14 mg, magnesium stearate 10.66 mg, light liquid paraffin 5 mg, xylitab 100 (xylitol (min 95%), polydextrose) 25 , 2 mg, cooling flavor (diethyl malonate, maltodextrin, menthol, methyl lactate, modified E1450 starch, isopulegol) 15 mg, menthol flavor (maltodextrin, menthol, modified starch E1450) 15 mg.

Description:Square tablets from white to white with a light brown color with concave surfaces, engraved "RENNIE" on both sides, with a smell of menthol. Small spots are allowed (for chewing tablets [cooling taste]).

Pharmacotherapeutic group:Antacid agent

ATX: & nbsp

A.02.A.X Antacids in combination with other drugs

Pharmacodynamics:

The drug neutralizes excess acid in the stomach, thereby providing a protective effect on the gastric mucosa. The rapid achievement of a positive effect is due to the good solubility of the tablets.

Indications:Symptoms associated with high acidity of gastric juice and reflux esophagitis: heartburn, acidic eructation, periodic pain in the stomach, feeling of overflow or heaviness in the epigastric region, dyspepsia (including those caused by inaccuracies in diet, medication, alcohol abuse, coffee , nicotine), dyspepsia of pregnant women.

Contraindications:Severe renal failure, hypercalcemia, hypophosphatemia, nephrocalcinosis, hypersensitivity to drug components, sugarase / isomaltase deficiency, fructose intolerance, glucose-galactose malabsorption, children under 12 years.

Dosing and Administration:Inside.
Adults and children over 12 years of age: if the doctor is not recommended otherwise, when symptoms appear, 1-2 tablets chew (or keep in the mouth until completely dissolved).
If necessary, you can repeat the drug after 2 hours.
The maximum daily dose is 11 tablets.

Side effects:

With the recommended doses, Rennie is usually well tolerated. Nevertheless, allergic reactions are possible, a change in the consistency of the stool. If antacids are taken in high doses, within a few hours from the time of the last intake compensated hypersecretion of gastric juice can be observed. In patients with renal failure, RENNI can cause hypermagnesemia and hypercalcemia.

Interaction:

Changing the acidity of gastric juice, during the use of antacids, can lead to a decrease in the rate and extent of absorption of other drugs, while taking, so drugs should be taken 1-2 hours before or after taking antacid preparations. Antibiotics of tetracycline, fluoroquinolones, cardiac glycosides, levothyroxine, iron preparations, fluorides, phosphates - with simultaneous use of antacids reduce the absorption of these drugs. Thiazide diuretics - with simultaneous administration with antacids should regularly monitor the concentration of calcium in the blood serum.

Special instructions:

When appointing the drug, patients with impaired renal function should regularly monitor the concentration of magnesium, phosphorus and calcium in the blood serum. Patients with impaired renal function are not recommended to take the drug for a long time in high doses.

The use of Rennie® in high doses may increase the risk of kidney stones.

Indication for patients with diabetes:

1 tablet of Rennie® contains 475 mg of sucrose.

If the drug is not effective, you should consult your doctor for advice.

Form release / dosage:Tablets are chewable, pills chewing [cooling taste].

Packaging:

Chewable tablets (blister)

For 6 tablets in a heat-sealed aluminum / PVC blister. By 2, 4. 6, 8 and 16 blisters together with instructions for use in a cardboard box.

For 12 tablets in a heat-sealed aluminum / PVC blister. For 1, 2. 3, 4 and 8 blisters together with instructions for use in a cardboard box.

Tablets chewing (strip)

2 tablets in PET / aluminum / PE countries. For 18 strips together with instructions for use in cardboard pack.

Tablets chewing [cooling taste] (blister)

For 6 tablets in a heat-sealed aluminum / PVC blister. By 2, 4, 6, 8 and 16 blisters together with the instruction in a cardboard box.

For 12 tablets in a heat-sealed aluminum / PVC blister. By 1, 2, 3, 4 and 8 blisters together with the instruction but application in a cardboard box.

Storage conditions:

At a temperature of no higher than 25 ° C.

Keep out of the reach of children.

Shelf life:

Tablets, chewing (blister): 5 years. Tablets chewing (strip):

2 years.

Tablets chewing [cooling taste] (blister): 3 years.

Do not use after the expiration date.

Terms of leave from pharmacies:Without recipe

Registration number:П N012507 / 01

Date of registration:03.08.2010

The owner of the registration certificate:BAYER, AO BAYER, AO Russia

Manufacturer: & nbsp

DELPHARM GIALLARD France

Information update date: & nbsp14.09.2015

Illustrated instructions

Instructions

Rennie® (Rennie®)